Trial Profile
Effects of Tenofovir on Pharmacokinetics of Morinidazole in Healthy Chinese Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Mar 2020
Price :
$35
*
At a glance
- Drugs Morinidazole (Primary) ; Tenofovir
- Indications Bacterial infections
- Focus Pharmacokinetics
- Sponsors Shanghai Hansoh Biomedical
- 09 Mar 2020 Status has been changed to completed.
- 09 Mar 2020 Results assessing effects of Tenofovir on Single-dose Pharmacokinetics of Intravenous Morinidazole in Healthy Chinese Subjects, published in the Antimicrobial Agents and Chemotherapy
- 03 Aug 2017 New trial record